Comparison of Three Sample Size Calculation Methods for Non-Inferiority Vaccine Trials With Multiple Continuous Co-Primary Endpoints
Human Vaccines and Immunotherapeutics - United States
doi 10.1080/21645515.2018.1514221
Full Text
Open PDFAbstract
Available in full text
Date
October 4, 2018
Authors
Publisher
Informa UK Limited